Glioblastoma multiforme is a highly malignant brain tumor with significant intra-and
intertumoral heterogeneity known for its aggressive nature and poor prognosis. The complex …

Glioma, the most common primary malignant tumor in the central nervous system (CNS),
lacks effective treatments, and> 60% of cases are glioblastoma (GBM), the most aggressive …

Glioblastoma recurrence is currently inevitable despite extensive standard-of-care treatment.
In preclinical studies, an alternative strategy of targeting tumor-associated macrophages and …

The fight against Glioblastoma multiforme (GBM) is ongoing and the long-term outlook for
GBM remains challenging due to low prognosis but every breakthrough brings us closer to …

Background Little is known about the growth dynamics of untreated glioblastoma and its
possible influence on postoperative survival. Our aim was to analyze a possible association …

Background/Aim: Presurgical tumor volume progression in glioblastoma (GBM) may be a
predictor of survival. This study aims to evaluate the potential impact of preoperative tumor …

Glioblastoma (GB) are aggressive, primary brain tumors, for which standard therapy
comprises surgical resection followed by radio-chemotherapy [1-3]. Despite this multimodal …

1.1 Glioblastoma 1.1. 1 Epidemiology, therapy and diagnosis World-wide brain and nervous
system tumors comprise 1.6% of all newly diagnosed cancers [6]. Glioblastoma (GB) are …

Glioblastome stellen die häufigsten, malignen primären Hirntumore dar. Trotz maximaler
Therapie ist das durchschnittliche Langzeitüberleben betroffener Patienten mit 17-24 …